Stock listing
NASDAQ:GLSI Greenwich LifeSciences, Inc. Stock
Home listing (NASDAQ) of Greenwich LifeSciences, Inc.
Follow Greenwich LifeSciences, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:GLSI
$19.25 USD -1.33 (-6.5%)
Close on Nov 20, 2026
- Day range
- $18.40 – $20.20 USDNov 20, 2026
- Volume
- 472,105 sharesNov 20, 2026
- Market cap
- $282.6M USDAt the close on Nov 20, 2026 · price × 14.68M shares outstanding
- 52-week range
- $7.78 – $34.10 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2.75M USDMedian day 118,800 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GLSI · Home | $19.25 USD | -1.33 (-6.5%) | 472,105 | $19.50 | $20.20 | $18.40 | $20.58 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:GLSI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $19.25 | -1.33 | -6.5% | $19.50 | $20.20 | $18.40 | 472,105 | |
| $20.58 | +1.88 | +10.1% | $18.60 | $21.98 | $18.24 | 714,006 | |
| $18.70 | +4.94 | +35.9% | $16.06 | $19.28 | $15.73 | 1,107,222 | |
| $13.76 | -1.18 | -7.9% | $14.81 | $15.04 | $13.38 | 153,779 | |
| $14.94 | -0.34 | -2.2% | $15.87 | $15.87 | $14.56 | 75,281 | |
| $15.28 | -0.81 | -5.0% | $15.80 | $16.08 | $14.40 | 207,011 | |
| $16.09 | +0.02 | +0.1% | $16.48 | $16.78 | $16.00 | 118,600 | |
| $16.07 | -0.45 | -2.7% | $16.29 | $16.80 | $15.80 | 84,100 | |
| $16.52 | +1.35 | +8.9% | $15.53 | $17.07 | $15.16 | 157,700 | |
| $15.17 | +0.52 | +3.5% | $14.91 | $15.75 | $14.54 | 80,900 | |
| $14.65 | -1.70 | -10.4% | $16.19 | $16.35 | $14.11 | 250,100 | |
| $16.35 | +0.43 | +2.7% | $16.46 | $16.95 | $15.76 | 135,700 | |
| $15.92 | -0.54 | -3.3% | $16.70 | $17.21 | $15.89 | 66,100 | |
| $16.46 | -0.95 | -5.5% | $17.69 | $17.69 | $16.23 | 118,500 | |
| $17.41 | -1.59 | -8.4% | $18.47 | $18.77 | $17.04 | 174,600 | |
| $19.00 | +0.69 | +3.8% | $18.31 | $19.50 | $18.08 | 121,900 | |
| $18.31 | +0.89 | +5.1% | $17.22 | $18.44 | $17.00 | 130,000 | |
| $17.42 | +0.295 | +1.7% | $17.19 | $17.58 | $16.66 | 224,300 | |
| $17.13 | +1.095 | +6.8% | $16.01 | $17.44 | $15.86 | 118,800 | |
| $16.03 | +0.55 | +3.6% | $15.40 | $16.09 | $14.79 | 86,500 | |
| $15.48 | -1.09 | -6.6% | $16.02 | $16.77 | $15.21 | 96,400 | |
| $16.57 | +0.33 | +2.0% | $16.41 | $16.67 | $16.16 | 82,000 | |
| $16.24 | +1.03 | +6.8% | $15.10 | $16.44 | $15.10 | 101,500 | |
| $15.21 | +0.66 | +4.5% | $14.84 | $15.39 | $14.75 | 151,900 | |
| $14.55 | -0.77 | -5.0% | $15.30 | $15.53 | $14.41 | 107,700 | |
| $15.32 | -0.08 | -0.5% | $15.12 | $15.61 | $15.10 | 81,300 | |
| $15.40 | -0.10 | -0.6% | $15.25 | $16.35 | $15.15 | 137,800 | |
| $15.50 | -2.27 | -12.8% | $17.50 | $17.75 | $14.06 | 317,100 | |
| $17.77 | +1.24 | +7.5% | $16.45 | $18.00 | $16.42 | 163,200 | |
| $16.53 | +1.39 | +9.2% | $15.20 | $16.80 | $15.20 | 119,400 | |
| $15.14 | -0.25 | -1.6% | $15.29 | $16.14 | $14.55 | 129,100 | |
| $15.39 | -0.40 | -2.5% | $15.81 | $16.37 | $15.00 | 147,200 | |
| $15.79 | -1.12 | -6.6% | $17.02 | $17.32 | $15.40 | 113,600 | |
| $16.91 | -0.07 | -0.4% | $16.92 | $17.25 | $16.26 | 98,700 | |
| $16.98 | -0.37 | -2.1% | $17.65 | $18.25 | $16.60 | 175,400 | |
| $17.35 | -0.70 | -3.9% | $18.12 | $18.35 | $16.81 | 121,500 | |
| $18.05 | -0.33 | -1.8% | $18.60 | $19.31 | $18.01 | 145,000 | |
| $18.38 | -0.21 | -1.1% | $18.78 | $19.21 | $18.20 | 65,700 | |
| $18.59 | +0.37 | +2.0% | $18.12 | $19.00 | $17.85 | 82,900 | |
| $18.22 | +0.12 | +0.7% | $18.00 | $18.69 | $18.00 | 66,700 | |
| $18.10 | +0.59 | +3.4% | $17.46 | $18.15 | $17.30 | 88,100 | |
| $17.51 | -1.97 | -10.1% | $19.31 | $19.36 | $17.12 | 187,100 | |
| $19.48 | +0.885 | +4.8% | $18.58 | $20.31 | $18.31 | 122,800 | |
| $18.60 | -0.395 | -2.1% | $19.20 | $19.24 | $18.12 | 110,100 | |
| $18.99 | +0.60 | +3.3% | $18.40 | $20.04 | $18.25 | 302,300 | |
| $18.39 | +2.76 | +17.7% | $16.04 | $18.75 | $16.04 | 247,000 | |
| $15.63 | -0.46 | -2.9% | $16.09 | $16.37 | $15.35 | 121,600 | |
| $16.09 | +0.04 | +0.2% | $15.81 | $16.43 | $15.35 | 96,800 | |
| $16.05 | +0.60 | +3.9% | $15.15 | $16.30 | $15.15 | 100,200 | |
| $15.45 | +0.39 | +2.6% | $15.33 | $15.60 | $15.09 | 74,800 | |
| $15.06 | +0.03 | +0.2% | $14.54 | $15.35 | $14.46 | 68,500 | |
| $15.03 | -0.87 | -5.5% | $15.79 | $16.34 | $14.90 | 103,300 | |
| $15.90 | -0.05 | -0.3% | $15.71 | $16.25 | $15.53 | 63,000 | |
| $15.95 | +0.32 | +2.0% | $15.45 | $15.98 | $15.45 | 65,000 | |
| $15.63 | -0.11 | -0.7% | $15.80 | $16.02 | $15.50 | 46,700 | |
| $15.74 | +0.73 | +4.9% | $15.01 | $16.02 | $14.99 | 102,800 | |
| $15.01 | +0.06 | +0.4% | $14.56 | $15.08 | $14.40 | 98,600 | |
| $14.95 | -0.72 | -4.6% | $15.50 | $15.62 | $14.32 | 169,500 | |
| $15.67 | -3.06 | -16.3% | $18.77 | $18.94 | $14.25 | 370,600 | |
| $18.73 | +0.50 | +2.7% | $18.04 | $18.89 | $18.01 | 64,200 | |
| $18.23 | -0.36 | -1.9% | $18.60 | $18.61 | $17.82 | 60,900 | |
| $18.59 | +1.01 | +5.7% | $17.46 | $19.64 | $17.44 | 199,132 | |
| $17.58 | +0.91 | +5.5% | $16.64 | $17.68 | $15.78 | 93,545 | |
| $16.67 | +1.36 | +8.9% | $16.16 | $17.48 | $15.54 | 176,700 | |
| $15.31 | -2.03 | -11.7% | $17.41 | $17.68 | $15.00 | 181,600 |
- Ticker
- NASDAQ:GLSI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 41 slides
Latest news
Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026
Nov 17, 2026
Closed $18.70 (+35.9%) on Nov 17, 2026
Greenwich LifeSciences Interview to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Nov 13, 2026
Closed $14.94 (-2.2%) on Nov 13, 2026
Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027
Aug 10, 2026
Closed $15.50 (+7.9%) on Aug 10, 2026
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
Jul 22, 2026
Closed $13.27 (-9.4%) on Jul 22, 2026
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
Jul 20, 2026
Closed $14.07 (-13.8%) on Jul 20, 2026
Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01
Jul 16, 2026
Closed $19.01 (-2.7%) on Jul 16, 2026
Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
Jul 9, 2026
Closed $19.57 (+3.7%) on Jul 9, 2026
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
Jun 1, 2026
Closed $28.51 (+8.9%) on Jun 1, 2026
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
May 22, 2026
Closed $27.39 (-0.9%) on May 26, 2026
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
Apr 30, 2026
Closed $23.62 (+9.4%) on Apr 30, 2026
Greenwich LifeSciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 123 in all · newest Nov 17, 2026 · oldest 2020
- Decks
- 8 decks · latest September 2026
Where Greenwich LifeSciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GLSI · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GLSI | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $276.7M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 2.80
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Greenwich LifeSciences, Inc. · NASDAQ:GLSI | US$282.6M | US$276.7M | n/a | n/a | n/a | n/a | n/a | n/a | 2.80 |
| Contineum Therapeutics, Inc. · NASDAQ:CTNM | US$286.1M | US$47.86M | n/a | n/a | n/a | 1.2× | n/a | 0.0× | 1.53 |
| TRex Bio, Inc. · NASDAQ:TRXB | US$283.1M | US$205.0M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Precision BioSciences, Inc. · NASDAQ:DTIL | US$282.5M | US$228.3M | n/a | 5.1× | n/a | 5.5× | −85.6% | 0.5× | 0.30 |
| AP Biosciences, Inc. · TPEX:6945 | US$282.3M | US$215.7M | n/a | n/a | n/a | 4.0× | n/a | 0.0× | n/a |
| Fulcrum Therapeutics, Inc. · NASDAQ:FULC | US$281.8M | −US$17.87M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | 0.42 |
| Circio Holding ASA · OSL:CRNA | US$281.1M | US$225.8M | n/a | n/a | n/a | 5.3× | n/a | 0.0× | n/a |
| Relmada Therapeutics, Inc. · NASDAQ:RLMD | US$279.5M | US$77.42M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 1.57 |
| Benitec Biopharma Inc. · NASDAQ:BNTC | US$276.1M | US$99.78M | n/a | n/a | n/a | 1.6× | n/a | 0.0× | 1.46 |
| Galectin Therapeutics Inc. · NASDAQ:GALT | US$271.4M | US$293.0M | n/a | n/a | n/a | n/a | n/a | n/a | 1.20 |
| Vicore Pharma Holding AB · OMXSTO:VICO | US$271.2M | US$182.6M | n/a | 467× | n/a | 3.3× | n/a | 0.0× | n/a |
| Median of the others | US$281.5M | US$193.8M | 236× | 2.4× | −85.6% | 0.0× | 1.33 |
Forecasts
2 strong buy · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 57.50 USD · Analysts' mean
- EPS, year to Dec 2026
- -1.48 · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Snehal S. Patel | Chief Executive Officer, Board Member |
| Eric Rothe | Founder, Board Member |
| F. Joseph Daugherty | Chief Medical Officer, Board Member |
Board
| Director | Role |
|---|---|
| David B. McWilliams | Chairman of the Board |
| Eric Rothe | Founder, Board Member |
| F. Joseph Daugherty | Chief Medical Officer, Board Member |
| Kenneth Hallock | Board Member |
| Snehal S. Patel | Chief Executive Officer, Board Member |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 20, 2026 · After close | |
| Q2 2026 | Aug 11, 2026 · After close | +8.8% |
| Q1 2026 | May 26, 2026 · After close | +6.7% |
| Q4 2025 | Feb 25, 2026 | +13.0% |
| Q3 2025 | Nov 14, 2025 · After close | −1.1% |
| Q2 2025 | Aug 14, 2025 · After close | +0.8% |
| Q1 2025 | May 20, 2025 · After close | −5.5% |
| Q4 2024 | Feb 26, 2025 | −0.3% |
| Q3 2024 | Nov 14, 2024 · After close | −7.6% |
| Q2 2024 | Aug 14, 2024 · After close | +4.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 20, 2024 · After close | +3.5% |
| Q4 2023 | Mar 31, 2024 · After close | −4.5% |
| Q3 2023 | Oct 19, 2023 · After close | +0.1% |
| Q2 2023 | Aug 21, 2023 · After close | −1.5% |
| Q1 2023 | May 22, 2023 · After close | −1.7% |
| Q4 2022 | Mar 1, 2023 | −6.2% |
| Q3 2022 | Nov 14, 2022 · After close | +11.8% |
| Q2 2022 | Aug 15, 2022 · After close | −4.0% |
| Q1 2022 | May 20, 2022 · After close | +4.3% |
| Q4 2021 | Mar 21, 2022 · After close | +4.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2026) | Investor deck | 41 slides | September 2026 |
| Investor Presentation (June 2025) | Investor deck | 36 slides | June 2025 |
| Investor Presentation (April 2025) | Investor deck | 36 slides | April 2025 |
| Investor Presentation (November 2021) | Investor deck | 40 slides | Nov 10, 2021 |
| Investor Presentation (November 2020) | Investor deck | 27 slides | Nov 19, 2020 |
| Investor Presentation (October 2020) | Investor deck | 25 slides | Oct 9, 2020 |
| IPO Roadshow (September 2020) | IPO roadshow | 14 slides | Sep 22, 2020 |
| IPO Roadshow (June 2020) | IPO roadshow | 14 slides | Jun 23, 2020 |
Financings
| Raise | Date |
|---|---|
| At-the-market programme of common stock Tranche closed: US$7M raised · H.C. Wainwright Dealers: H.C. Wainwright | Apr 14, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$5.75 a share on Sep 24, 2020.
- Price
- US$5.75 a share
- Shares offered
- 1,260,870 shares of common stock
- Offering size
- US$7.3 million
- Underwriters' option
- Up to 189,130 more shares
- Listing
- GLSI on the Nasdaq Capital Market
- Shares delivered
- On or about Sep 29, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 28, 2020 |
| Filed publicly | May 29, 2020 |
| Amended 4 times | Newest Sep 10, 2020 |
| Shares registered with an exchange | Sep 23, 2020 |
| Declared effective by the SEC | Sep 24, 2020 |
| Final prospectus, with the price | Sep 28, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 28, 2020 |
| 424B4 · Prospectus | Sep 28, 2020 |
| EFFECT · Notice that a registration is effective | Sep 24, 2020 |
| CERT · Exchange's certificate of listing | Sep 24, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 23, 2020 |
| CORRESP · Letter to the SEC | Sep 22, 2020 |
| CORRESP · Letter to the SEC | Sep 22, 2020 |
| FWP · Free writing prospectus | Sep 22, 2020 |
| S-1/A · Registration statement, amended | Sep 10, 2020 |
| S-1/A · Registration statement, amended | Sep 9, 2020 |
All 24 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Jun 26, 2020 |
| S-1/A · Registration statement, amended | Jun 26, 2020 |
| UPLOAD · Letter from the SEC | Jun 25, 2020 |
| FWP · Free writing prospectus | Jun 23, 2020 |
| S-1/A · Registration statement, amended | Jun 23, 2020 |
| CORRESP · Letter to the SEC | Jun 22, 2020 |
| UPLOAD · Letter from the SEC | Jun 10, 2020 |
| S-1 · Registration statement | May 29, 2020 |
| CORRESP · Letter to the SEC | May 29, 2020 |
| UPLOAD · Letter from the SEC | Apr 16, 2020 |
| DRSLTR · Letter to the SEC with a draft | Apr 7, 2020 |
| DRS/A · Draft registration statement, amended | Apr 7, 2020 |
| UPLOAD · Letter from the SEC | Feb 20, 2020 |
| DRS · Draft registration statement | Jan 28, 2020 |
Open IPO · From the cover of the final prospectus (424B4) filed Sep 28, 2020
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cost of revenue | 1.78K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K |
| Gross profit | -1.78K | -3.61K | -3.61K | -3.61K | -3.61K | -3.61K | -3.61K | -3.61K | -3.61K |
| Research and development | 17.2M | 15.5M | 7.70M | 6.48M | 3.56M | 1.06M | 2.61M | 1.27M | 1.22M |
| Selling, general and administrative | 2.23M | 3.06M | 1.63M | 1.56M | 1.04M | 806.2K | 818.9K | 419.6K | |
| Operating income | -19.4M | -17.6M | -9.33M | -8.04M | -4.60M | -1.86M | -3.43M | -1.69M | -1.57M |
| Depreciation and amortization | 1.78K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K | 3.61K |
| EBITDA | -19.4M | -17.6M | -9.32M | -8.04M | -4.59M | -1.86M | -3.42M | -1.69M | -1.57M |
| Interest expense | 215.0K | 27.4K | 0 | 0 | 0 | ||||
| Income before tax | -19.4M | -17.4M | -8.89M | -7.83M | -4.57M | -1.86M | -3.43M | -1.69M | -1.57M |
| Income tax | -2 | -215.0K | -27.4K | -832 | 3 | -157.5K | 3 | ||
| Net income | -19.4M | -17.4M | -8.89M | -7.83M | -4.57M | -1.86M | -3.43M | -1.69M | -1.57M |
| Earnings per share, basic | -1.43 | -1.34 | -0.69 | -0.61 | -0.35 | -0.20 | -1.52 | -0.14 | -0.13 |
| Earnings per share, diluted | -1.43 | -1.34 | -0.69 | -0.61 | -0.35 | -0.20 | -1.52 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6.18M | 4.09M | 6.99M | 13.5M | 27.2M | 28.7M | 6.83K | 85.1K | 54 |
| Current assets | 6.18M | 4.09M | 6.99M | 13.5M | 27.2M | 28.7M | 6.83K | 85.1K | 54 |
| Total assets | 6.18M | 4.09M | 6.99M | 13.5M | 27.2M | 28.7M | 26.7K | 108.5K | 27.1K |
| Accounts payable | 4.65M | 1.18M | 35.5K | 220.8K | 220.8K | 711.0K | 730.3K | 277.6K | 161.1K |
| Current liabilities | 5.82M | 3.19M | 294.4K | 262.9K | 385.2K | 1.05M | 1.38M | 728.6K | 557.5K |
| Total debt | 275.2K | 635.2K | 420.2K | ||||||
| Total liabilities | 5.82M | 3.19M | 294.4K | 262.9K | 385.2K | 1.05M | 1.38M | 10.2M | 8.56M |
| Shareholders' equity | 353.2K | 908.6K | 6.70M | 13.2M | 26.8M | 27.6M | -1.35M | -10.1M | -8.53M |
| Shares outstanding | 14.3M | 13.2M | 12.8M | 12.8M | 13.1M | 12.7M | 8.46M | 12.0M | 11.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -9.91M | -7.27M | -6.48M | -6.20M | -4.29M | -1.15M | -293.3K | -115.0K | -120.8K |
| Capital spending | -3 | -3 | 0 | -3 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | -9.91M | -7.27M | -6.48M | -6.20M | -4.29M | -1.15M | -293.3K | -115.0K | -120.8K |
| Cash from financing | 12.0M | 4.37M | 0 | -7.54M | 2.84M | 29.8M | 215.0K | 200.0K | -129.8K |
| Share buybacks | 0 | -7.54M | 3.11M | 30.2M | -90.0K | ||||
| Change in cash | 2.09M | -2.90M | -6.48M | -13.7M | -1.46M | 28.7M | -78.3K | 85.0K | -250.7K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Oct 26, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Oct 26, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Oct 26, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 11, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 27, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Jun 3, 2026 | Quarterly report | SEC |
| 10-K · Annual report | Jun 1, 2026 | Annual report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 18, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Nov 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Nov 3, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Nov 3, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Nov 3, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 24, 2025 | Current report | SEC |
| 10-Q · Quarterly report | May 20, 2025 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2025 | Explanation request | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 22, 2025 | Insider trade | SEC |
| 10-K · Annual report | Apr 15, 2025 | Annual report | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2025 | Insider trade | SEC |
| NT 10-K · Late filing notice | Mar 31, 2025 | Explanation request | SEC |
| 4 · Change in ownership | Jan 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 27, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Dec 20, 2024 | Offer document | SEC |
| 8-K · Current report | Dec 19, 2024 | Meeting outcome | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Nov 1, 2024 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Nov 1, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Nov 1, 2024 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Oct 18, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 15, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Oct 11, 2024 | Other filings | SEC |
| S-3 · Registration statement | Oct 7, 2024 | Offer document | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 16, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 22, 2024 | Insider trade | SEC |
| D | Jun 17, 2024 | Other filings | SEC |
| 8-K · Current report | Jun 17, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jun 17, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 20, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2024 | Explanation request | SEC |
| 10-K · Annual report | Apr 15, 2024 | Annual report | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| NT 10-K · Late filing notice | Apr 1, 2024 | Explanation request | SEC |
| 4 · Change in ownership | Mar 26, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 22, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Mar 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 20, 2024 | Current report | SEC |
| 4 · Change in ownership | Feb 20, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 14, 2024 | Current report | SEC |
| 8-K · Current report | Dec 15, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Nov 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 7, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 31, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 27, 2023 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Oct 25, 2023 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Oct 24, 2023 | Annual report | SEC |
| DEF 14A · Proxy statement | Oct 24, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Oct 19, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 21, 2023 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2023 | Explanation request | SEC |
| 4 · Change in ownership | Aug 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 17, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 22, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | May 18, 2023 | Insider trade | SEC |
| NT 10-Q · Late filing notice | May 15, 2023 | Explanation request | SEC |
| 4 · Change in ownership | May 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 20, 2023 | Insider trade | SEC |
| 8-K · Current report | Apr 13, 2023 | Current report | SEC |
| 4 · Change in ownership | Apr 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 12, 2023 | Insider trade | SEC |
| 10-K · Annual report | Mar 31, 2023 | Annual report | SEC |
| 4 · Change in ownership | Mar 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Mar 13, 2023 | Current report | SEC |
| 4 · Change in ownership | Feb 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 31, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 13, 2022 | Insider trade | SEC |
| 8-K · Current report | Dec 9, 2022 | Meeting outcome | SEC |
| 4 · Change in ownership | Dec 6, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 6, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 4, 2022 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Oct 19, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 19, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Oct 17, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 15, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jul 12, 2022 | Material contract | SEC |
| 424B5 · Prospectus | Jul 12, 2022 | Offer document | SEC |
| 8-K · Current report | Jul 12, 2022 | Current report | SEC |
| 8-K · Current report | Jul 11, 2022 | Current report | SEC |
| S-8 · Registration statement for employee plans | Jul 5, 2022 | Offer document | SEC |
| 4 · Change in ownership | Jun 27, 2022 | Insider trade | SEC |
| 10-K/A · Annual report, amended | Jun 24, 2022 | Annual report | SEC |
| 4 · Change in ownership | Jun 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2022 | Insider trade | SEC |
| SC 13G · Big-stake notice | Jun 22, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 17, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 15, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | May 20, 2022 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 16, 2022 | Explanation request | SEC |
| 4 · Change in ownership | Apr 26, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 22, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 21, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 20, 2022 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Apr 7, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Apr 4, 2022 | Other filings | SEC |
| S-3/A · Registration statement, amended | Apr 1, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Mar 31, 2022 | Other filings | SEC |
| S-3 · Registration statement | Mar 25, 2022 | Offer document | SEC |
| 10-K · Annual report | Mar 21, 2022 | Annual report | SEC |
| 4 · Change in ownership | Feb 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 8, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Feb 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 24, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 19, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 18, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 4, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 16, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 16, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Dec 16, 2021 | Insider trade | SEC |
| 8-K · Current report | Dec 15, 2021 | Meeting outcome | SEC |
| 8-K · Current report | Dec 13, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2021 | Current report | SEC |
| DEFA14A · Additional proxy material | Oct 20, 2021 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 19, 2021 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 13, 2021 | Quarterly report | SEC |
| 8-K · Current report | Jun 10, 2021 | Current report | SEC |
| 8-K · Current report | Jun 9, 2021 | Current report | SEC |
| 10-Q · Quarterly report | May 20, 2021 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 17, 2021 | Explanation request | SEC |
This page holds 200 of 280 filings. Open Filings
Cap table
Built by 6ix from Greenwich LifeSciences, Inc.’s releases · as of Nov 6, 2026
- Common shares
- 14,678,208
- Fully diluted
- 14,678,208
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 14,678,208 | Nov 6, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 6, 2026 | 14,678,208 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David B. McWilliams Other companies: Acer Therapeutics Inc (Director · Feb 17, 2006 – Aug 26, 2009 · Past) | Chairman of the Board · Since at least Sep 24, 2020 |
| Eric Rothe | Founder, Board Member · Since at least Sep 24, 2020 |
| F. Joseph Daugherty | Chief Medical Officer, Board Member · Since at least Nov 4, 2026 |
| Frank Joseph Daugherty | Chief Medical Officer, Director · Sep 24, 2020 – Dec 24, 2024 · Past |
| Jaye Thompson | VP Clinical Reg Affairs · Sep 24, 2020 – Dec 24, 2024 · Past |
| Kenneth Hallock | Board Member · Since at least Sep 24, 2020 |
| Snehal S. Patel | Chief Executive Officer, Board Member · Since at least Sep 24, 2020 |
Log in to ask 6ix AI your own questions about Greenwich LifeSciences, Inc.